531 related articles for article (PubMed ID: 31243883)
1. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC
Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.
Gall TMH; Belete S; Khanderia E; Frampton AE; Jiao LR
Am J Pathol; 2019 Jan; 189(1):71-81. PubMed ID: 30558725
[TBL] [Abstract][Full Text] [Related]
4. Mutant
Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsies in pancreatic cancer.
Kamyabi N; Bernard V; Maitra A
Expert Rev Anticancer Ther; 2019 Oct; 19(10):869-878. PubMed ID: 31533487
[No Abstract] [Full Text] [Related]
6. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
8. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.
Cohen JD; Javed AA; Thoburn C; Wong F; Tie J; Gibbs P; Schmidt CM; Yip-Schneider MT; Allen PJ; Schattner M; Brand RE; Singhi AD; Petersen GM; Hong SM; Kim SC; Falconi M; Doglioni C; Weiss MJ; Ahuja N; He J; Makary MA; Maitra A; Hanash SM; Dal Molin M; Wang Y; Li L; Ptak J; Dobbyn L; Schaefer J; Silliman N; Popoli M; Goggins MG; Hruban RH; Wolfgang CL; Klein AP; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Lennon AM
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10202-10207. PubMed ID: 28874546
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer.
Rofi E; Vivaldi C; Del Re M; Arrigoni E; Crucitta S; Funel N; Fogli S; Vasile E; Musettini G; Fornaro L; Falcone A; Danesi R
Pharmacogenomics; 2019 Jan; 20(1):49-68. PubMed ID: 30520336
[TBL] [Abstract][Full Text] [Related]
10. Cytologic characteristics of circulating epithelioid cells in pancreatic disease.
Rosenbaum MW; Cauley CE; Kulemann B; Liss AS; Castillo CF; Warshaw AL; Lillemoe KD; Thayer SP; Pitman MB
Cancer Cytopathol; 2017 May; 125(5):332-340. PubMed ID: 28257167
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
12. Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer.
Grunvald MW; Jacobson RA; Kuzel TM; Pappas SG; Masood A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081107
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V
Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
Takai E; Yachida S
World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
[TBL] [Abstract][Full Text] [Related]
15. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
[TBL] [Abstract][Full Text] [Related]
16. Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer.
Lin M; Alnaggar M; Liang S; Chen J; Xu K; Dong S; Du D; Niu L
Cell Physiol Biochem; 2018; 47(4):1556-1564. PubMed ID: 29940591
[TBL] [Abstract][Full Text] [Related]
17. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
Babic A; Wolpin BM
Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
[No Abstract] [Full Text] [Related]
18. Prognostic markers in pancreatic ductal adenocarcinomas.
Hezel AF; Bardeesy N
Cancer Biol Ther; 2008 Sep; 7(9):1360-1. PubMed ID: 18836287
[No Abstract] [Full Text] [Related]
19. Pulmonary tumor embolism as an initial manifestation of pancreatic adenocarcinoma.
Sancho-Chust JN; Ferreres J; Pineda J; Molla MA; Giner F; Juan M; Blanquer J
Respir Care; 2009 Dec; 54(12):1732-5. PubMed ID: 19961641
[No Abstract] [Full Text] [Related]
20. Liquid biopsy: novel technologies and clinical applications.
Reimers N; Pantel K
Clin Chem Lab Med; 2019 Feb; 57(3):312-316. PubMed ID: 30465714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]